Article Details

Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human ... - PR Newswire

Retrieved on: 2022-02-22 00:31:14

Tags for this article:

Click the tags to see associated articles and topics

Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human ... - PR Newswire. View article details on hiswai:

Excerpt

"HBM9378/SKB378, a next-gen fully human monoclonal antibody, is developed from HBM's H2L2 platform. Its long half-life optimization and ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up